XML 52 R44.htm IDEA: XBRL DOCUMENT v3.24.3
Stock Incentive Plans (Tables)
9 Months Ended
Sep. 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Non-vested Restricted Stock Units Activity The table below summarizes the restricted stock unit ("RSU") activity for the nine months ended September 30, 2024:

 

 

 

 

 

Weighted-

 

 

 

 

 

 

Average

 

 

 

Shares

 

 

Fair Value

 

Unvested RSUs—December 31, 2023

 

 

36,329,881

 

 

$

10.56

 

Granted

 

 

10,371,334

 

 

 

11.85

 

Vested

 

 

(14,007,032

)

 

 

10.77

 

Forfeited

 

 

(1,146,672

)

 

 

10.57

 

Unvested RSUs—September 30, 2024

 

 

31,547,511

 

 

 

10.89

 

Summary of Share-based Compensation Arrangements by Share-based Payment Award The table below summarizes the stock option activity for the nine months ended September 30, 2024:

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

 

Weighted-

 

 

Remaining

 

 

Aggregate

 

 

 

 

 

 

Average

 

 

Contractual

 

 

Intrinsic

 

 

 

 

 

 

Exercise

 

 

Life

 

 

Value

 

 

 

Shares

 

 

Price

 

 

(in years)

 

 

(in thousands)

 

Options outstanding—December 31, 2023

 

 

35,788,469

 

 

$

2.96

 

 

 

4.0

 

 

$

301,563

 

Exercised

 

 

(8,743,936

)

 

 

2.74

 

 

 

 

 

 

 

Forfeited and canceled

 

 

(11,920

)

 

 

3.40

 

 

 

 

 

 

 

Options outstanding—September 30, 2024

 

 

27,032,613

 

 

$

3.04

 

 

 

3.4

 

 

$

216,631

 

Options exercisable—September 30, 2024

 

 

26,171,215

 

 

$

2.91

 

 

 

3.3

 

 

$

212,962

 

Options vested and expected to vest—September 30, 2024

 

 

27,008,353

 

 

$

3.03

 

 

 

3.3

 

 

$

216,537

 

Summary of Share-based Payment Arrangement, Expensed and Capitalized, Amount

Stock-Based Compensation—Stock-based compensation expense has been recorded in the accompanying condensed consolidated statements of operations and comprehensive income (loss) as follows for the three and nine months ended September 30, 2024 and 2023 (in thousands):

 

 

 

For the Three Months Ended

 

 

For the Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Cost of revenues

 

$

2,297

 

 

$

2,396

 

 

$

7,051

 

 

$

6,595

 

Research and development

 

 

12,164

 

 

 

6,359

 

 

 

34,750

 

 

 

18,833

 

Sales and marketing

 

 

6,637

 

 

 

9,257

 

 

 

19,150

 

 

 

25,264

 

General and administrative

 

 

21,027

 

 

 

21,739

 

 

 

66,270

 

 

 

53,779

 

Total stock-based compensation expense

 

$

42,125

 

 

$

39,751

 

 

$

127,221

 

 

$

104,471

 

 

2021 Employee Stock Purchase Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The fair value of the ESPP purchase rights sold during the nine months ended September 30, 2024 was estimated using the Black-Scholes option pricing model with the following assumptions:

Expected term (in years)

 

0.5

Expected volatility

 

25%-29%

Expected dividend yield

 

0%

Risk-free interest rate

 

5.2%-5.5%